Zurcher Kantonalbank »

Moonlake Immunot shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2024-03-31 $202k 4.0k 50.23
2023-12-31 $217k 3.6k 60.39

More positions owned by Zurcher Kantonalbank

Microsoft Corporation (MSFT)
Ubs Group SHS (UBS)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Linde SHS (LIN)

View all positions for Zurcher Kantonalbank

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot